159 related articles for article (PubMed ID: 17151577)
21. [Hepatitis C virus infection and primary hepatic large B-cell lymphoma: a non-fortuitous association. Case report and review of literature].
Condat B; Bonnet J; Hauuy MP; Collot V; Charlier A; Dugue L; Ngo Y; Maftouh A; Diche T; Bandin O; Guigui B; Asli B; Blazquez M
Gastroenterol Clin Biol; 2003 Dec; 27(12):1157-9. PubMed ID: 14770120
[TBL] [Abstract][Full Text] [Related]
22. [Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice].
van Agthoven M; Wittebol S; Budel LM; Uyl-de Groot CA; Kramer MH
Ned Tijdschr Geneeskd; 2004 Jan; 148(2):88-93. PubMed ID: 14753131
[TBL] [Abstract][Full Text] [Related]
23. [Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma].
Li YH; Jiang WQ; Huang HQ; Xu RH; Lin TY; Xia ZJ; He YJ; Guan ZZ
Ai Zheng; 2003 Apr; 22(4):401-3. PubMed ID: 12703998
[TBL] [Abstract][Full Text] [Related]
24. Primary uterine lymphoma: report of 2 cases and review of literature.
Hariprasad R; Kumar L; Bhatla DM; Kukreja M; Papaiah S
Am J Obstet Gynecol; 2006 Jul; 195(1):308-13. PubMed ID: 16813759
[TBL] [Abstract][Full Text] [Related]
25. Multiple clinical manifestation of HTLV1 infection in a single patient.
Narayan D; DaSilva D; Doshi M
West Indian Med J; 2003 Dec; 52(4):322-4. PubMed ID: 15040072
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Spina M; Simonelli C; Tirelli U
J Clin Oncol; 2007 Feb; 25(6):e7. PubMed ID: 17308261
[No Abstract] [Full Text] [Related]
27. Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors.
Schmitt CJ; Dietrich S; Ho AD; Witzens-Harig M
Ann Hematol; 2012 Mar; 91(3):391-7. PubMed ID: 21850390
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C Virus infection in Saudi Arab patients with B-cell non-Hodgkin's lymphoma.
Harakati MS; Abualkhair OA; Al-Knawy BA
Saudi Med J; 2000 Aug; 21(8):755-8. PubMed ID: 11423889
[TBL] [Abstract][Full Text] [Related]
29. [Non-Hodgkin's lymphoma: a new less toxic treatment doubles the prognosis].
Sabourin G
Perspect Infirm; 2012; 9(6):60. PubMed ID: 23234232
[No Abstract] [Full Text] [Related]
30. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
Zucca E; Roggero E; Maggi-Solcà N; Conconi A; Bertoni F; Reilly I; Castelli D; Pedrinis E; Piffaretti JC; Cavalli F
Haematologica; 2000 Feb; 85(2):147-53. PubMed ID: 10681721
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus, mixed cryoglobulinaemia and non-Hodgkin's lymphoma.
Mazzaro C; Efremov DG; Burrone O; Pozzato G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):428-34. PubMed ID: 9789144
[TBL] [Abstract][Full Text] [Related]
34. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM
Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771
[TBL] [Abstract][Full Text] [Related]
35. Synovial presentation of non-Hodgkin's lymphoma.
Jamieson KA; Beggs I; Robb JE
Br J Radiol; 1998 Sep; 71(849):980-2. PubMed ID: 10195017
[TBL] [Abstract][Full Text] [Related]
36. Anemia of cancer in intermediate-grade non-Hodgkin's lymphoma.
Morrow TJ; Volpe S; Gupta S; Tannous RE; Fridman M
South Med J; 2002 Aug; 95(8):889-96. PubMed ID: 12190227
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors of invasive non-Hodgkin's lymphoma].
Yu H; Hong XN; Li J; Peng LP; Ye L
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284
[TBL] [Abstract][Full Text] [Related]
38. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.
Verdonck LF; van Putten WL; Hagenbeek A; Schouten HC; Sonneveld P; van Imhoff GW; Kluin-Nelemans HC; Raemaekers JM; van Oers RH; Haak HL
N Engl J Med; 1995 Apr; 332(16):1045-51. PubMed ID: 7898521
[TBL] [Abstract][Full Text] [Related]
39. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
40. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
